Research Article

Sexual Effect of Platelet-to-Lymphocyte Ratio in Predicting Cardiovascular Mortality of Peritoneal Dialysis Patients

Table 1

Baseline characteristics of the study cohort.

VariableTotal ()Group 1 ()Group 2 () value

Age (years)0.011
Gender (female, , %)565 (39.3)260 (36.2)305 (42.4)0.015
BMI (kg/m2)0.944
SBP (mmHg)0.203
DBP (mmHg)0.830
History of CVD (, %)246 (17.1)115 (16.0)131 (18.2)0.263
Diabetes (, %)297 (20.7)131 (18.2)166 (23.1)0.023
HGB (g/L)0.117
ALB (g/L)36.9 ± 4.90.018
Plasma creatinine (μmol/L)0.012
UA (μmol/L)0.315
Total cholesterol (mmol/L)0.003
Platelet (×109/L)232.0 (183.0, 288.0)194.0(154.0,243.0)271.0(222.0,319.0)<0.001
Lymphocyte (×109/L)1.5 (1.2, 1.8)1.7 (1.4, 2.1)1.2 (1.0, 1.5)<0.001
PLR156.4 (118.1, 206.4)118.1 (96.3, 136.1)206.4 (178.9, 254.6)<0.001
eGFR (mL/min/1.73 m2)6.8(5.3, 8.8)6.7 (5.1, 8.8)7.0(5.5, 8.8)0.060
Platelet inhibitor (, %)85 (5.9)32 (4.5)53 (7.4)0.019
β-Blockers (, %)676 (47.0)325 (45.2)351 (48.8)0.170

Abbreviations: BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; CVD: cardiovascular disease; HGB: hemoglobin; ALB: serum albumin; UA: uric acid; PLR: the platelet-to-lymphocyte ratio; eGFR: estimated glomerular filtration rate; PLR: for groups: group 1 (≤156.43) and group 2(>156.43).